Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03728751 · ClinicalTrials.gov registry record · NA

Optimal Time for In-situ Dry Needling to Affect the Autonomic Nervous System

A NA study of Healthy, sponsored by Florida Gulf Coast University.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03728751: Completed NA study of Healthy, sponsored by Florida Gulf Coast University.

NCT03728751 is a NA study of Healthy that has completed, run by Florida Gulf Coast University. The registered enrollment target is 20 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03728751, a NA study of Healthy, has completed, sponsored by Florida Gulf Coast University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Assessing for optimal time dry needles need to remain inside the body to have positive effect on the nervous system

Primary Outcome

Change in pupil diameter measured with automated pupillometry device from Micromedical.

Conditions Studied

Interventions

  • PROCEDURE Dry needling

Study Locations (1)

Indiana

  • Integrated Therapy Practice PC - Hobart

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2018-09-01
Est. Completion 2018-10-29
Phase NA
Florida Gulf Coast University

11 total trials

What the finished NCT03728751 record still lists

NCT03728751 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Dry needling is the first listed.

NCT03728751 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT03728751 about?

NCT03728751 is a clinical study titled "Optimal Time for In-situ Dry Needling to Affect the Autonomic Nervous System". Assessing for optimal time dry needles need to remain inside the body to have positive effect on the nervous system

What is the current status of trial NCT03728751?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-09-01. Estimated completion is 2018-10-29.

What conditions does trial NCT03728751 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT03728751?

The interventions under investigation include: Dry needling (PROCEDURE).

Who is sponsoring clinical trial NCT03728751?

This trial is sponsored by Florida Gulf Coast University, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03728751 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03728751's enrollment target sits among peer trials

20 861st of 1090 higher than 194 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

  • NCT01630850 · 20 participants · NA

    Islet Transplantation in Patients With "Brittle" Type I Diabetes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03728751, the US trial registry maintained by the National Library of Medicine. NCT03728751 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.